Pharma Pricing & Market Access Speakers

 

Keynotes

 

  • Carla Deakin at World Pharma Pricing and Market Access
    Carla Deakin
    Associate Director, Office for Market Access
    NICE
    Andrew Dillon at World Pharma Pricing and Market Access
    Andrew Dillon
    Chief Executive
    National Institute for Health and Care Excellence
    Sebastien Le Roux at World Pharma Pricing and Market Access
    Sebastien Le Roux
    VP, Global Market Access & Healthcare Solutions
    Glaxo Smith Kline Inc
  • Farzana Malik at World Pharma Pricing and Market Access
    Farzana Malik
    Vice President Market Access
    Vicarius Pharma
    Thomas Mueller at World Pharma Pricing and Market Access
    Thomas Mueller
    Head of Pharmaceuticals
    G-BA
    Jeff Myers at World Pharma Pricing and Market Access
    Jeff Myers
    CEO
    Medicaid Health Plans of America
  • Alexander Natz at World Pharma Pricing and Market Access
    Alexander Natz
    Secretary General
    EUCOPE
    Tanya Potashnik at World Pharma Pricing and Market Access
    Tanya Potashnik
    Director Policy & Economic Analysis, Patented Medicine Prices Review Board
    Goverment Of Canada
    Anne Toni Rodgers at World Pharma Pricing and Market Access
    Anne Toni Rodgers
    Former Global Head Operations Payer And Real World Evidence
    AstraZeneca
  • Gundula Schneidewind at World Pharma Pricing and Market Access
    Gundula Schneidewind
    Vice President
    Takeda
    Rob Scott at World Pharma Pricing and Market Access
    Rob Scott
    Chief Medical Officer, VP, Head of Development
    AbbVie
    Keiko Tone at World Pharma Pricing and Market Access
    Keiko Tone
    VP Market Access
    Shionogi Limited
  • John Bardi at World Pharma Pricing and Market Access
    John Bardi
    Vice President Public Affairs and Digital Medicine Business Development
    Otsuka America Pharmaceuticals Inc.
    Shameer Khader at World Pharma Pricing and Market Access
    Shameer Khader
    Program Director (Healthcare Data Science and Bioinformatics)
    Northwell Health
    Diane Munch at World Pharma Pricing and Market Access
    Diane Munch
    Head of Global Pricing, Patient & Health Impact
    Pfizer

 

All speakers listed alphabetically

 

Nicola Allen, Senior Consultant, Precision Xtract

Nicola Allen at World Pharma Pricing and Market Access

John Alter, Vice President Pricing and Market Access, Pfizer

John Alter at World Pharma Pricing and Market Access

Adel Alzahrani, Senior Pharmacist, Saudi Food & Drug Authority

Adel Alzahrani at World Pharma Pricing and Market Access

Nadeem Ashraf, Digital Lead for Medical Affairs & PRA (Pricing, Reimbursement & Access) for Europe & Canada, Lilly

Cheryl Ball, VP, Evidera

Cheryl Ball at World Pharma Pricing and Market Access

John Bardi, Vice President Public Affairs and Digital Medicine Business Development, Otsuka America Pharmaceuticals Inc.

Katja Berg, Vice President of Operations and Payers Intelligence, Sanofi

Katja Berg at World Pharma Pricing and Market Access

Luc Boileau, Président-directeur general, Inesss

Luc Boileau at World Pharma Pricing and Market Access

Hassan Bruneo, Associate Director, Alnylam

Hassan Bruneo at World Pharma Pricing and Market Access

Anna Bucsics, Project Advisor, Mechanism of Coordinated Access to orphan medicinal products (MoCA)

Anna Bucsics at World Pharma Pricing and Market Access

John Carlsen, Vice President, Covance

José Luis Sánchez Chorro, Head of Market Access, Shire Pharmaceuticals

Wim Colle, President PAH Belgium, Flemish Patients Platform vzw

Wim Colle at World Pharma Pricing and Market Access

Francis Crawley, Executive Director, European Network for Research on Alternating Hemaplegia

Francis Crawley at World Pharma Pricing and Market Access

Emily Crossley, Co-founder, Duchenne U.K.

Emily Crossley at World Pharma Pricing and Market Access

Omar Dabbous, Vice President of Global HEOR and RWE, AveXis Inc

Omar Dabbous at World Pharma Pricing and Market Access

Carla Deakin, Associate Director, Office for Market Access, NICE

Jose Diaz, Group Director – JKT Cluster & Intercon Lead - WWHEOR Markets, Bristol Myers Squibb

Jose Diaz at World Pharma Pricing and Market Access

Andrew Dillon, Chief Executive, National Institute for Health and Care Excellence

Andrew Dillon at World Pharma Pricing and Market Access

Mark Duman, NW Service Champion, Diabetes U.K.

Will Dunlop, Head of Market Access, Mundipharma International Limited

Will Dunlop at World Pharma Pricing and Market Access

Jenny Ebert, Account Director, Genzyme Sanofi Corp

Jenny Ebert at World Pharma Pricing and Market Access

Jane Erickson, Vice President, Reimbursement Services, Covance Inc

Jane Erickson at World Pharma Pricing and Market Access

Jousseaume Etienne, Head of Oncology Market Access, Novartis Oncology

Jousseaume Etienne at World Pharma Pricing and Market Access

Kiri Fatania-Morley, Patient Advocate, Patient/Parent Advocate

Kiri Fatania-Morley at World Pharma Pricing and Market Access

Diar Fattah, Associate Director of Medicines Optimisation, N.H.S._Dartford Gravesham and Swanley C.C.G.

Diar Fattah at World Pharma Pricing and Market Access

Hans Peter Frank, Global Head of Integrated Solutions, Vifor Fresenius Medical Care Renal Pharma Ltd

Hans Peter Frank at World Pharma Pricing and Market Access

Ben Gannon, Head of International Government Affairs, Public Policy & Patient Engagement, Vertex Pharmaceuticals

Ben Gannon at World Pharma Pricing and Market Access

Fabrizio Gianfrate, Professor of Health Economics, Mkt Access Advisor, Universities of Rome and Ferrara

Martin Gibson, Chief Executive Officer, North West E Health Ltd

Martin Gibson at World Pharma Pricing and Market Access

Josie Godfrey, Independent, Duchenne U.K.

Josie Godfrey at World Pharma Pricing and Market Access

Wim Goettsch, Director of EUnetHTA JA3, Zorginstituut

Adrian Griffin, VP, HTA and Reimbursement Policy, Johnson & Johnson

Adrian Griffin at World Pharma Pricing and Market Access

Alex Grosvenor, Vice President, Global Pricing & Market Access, Precision Xtract

Alex Grosvenor at World Pharma Pricing and Market Access

Mohamed Hamada, Country Portfolio Lead, Women’s Health – Egypt & Sudan, Pfizer

Udo Hannemann, General Manager, Vistex

Emma Harvey, Former Senior Medical Director, Alexion Pharmaceuticals

Ansgar Hebborn, Head of Global H.T.A. and Payment Policy, F Hoffman La Roche Ag

Ansgar Hebborn at World Pharma Pricing and Market Access

Tony Hebden, Vice President of Health Economics and Outcomes Research, AbbVie

Tony Hebden at World Pharma Pricing and Market Access

Kasia Hein Peters, Vice President and Head of Marketing Dengue Vaccine, Sanofi Pasteur

Kasia Hein Peters at World Pharma Pricing and Market Access

Alan Hochberg, Process Development Leader and DSC Office, F. Hoffmann-La Roche Ltd

Karen Hockey, Director, Global Market Access & Government Affairs, Norgine Ltd

Patrick Homer, Global Life Sciences Commercial Practice Principal, SAS

Patrick Homer at World Pharma Pricing and Market Access

Patrick Hopkinson, Executive Director, WWHEOR Markets, Bristol-Myers Squibb

Alison Howell, Director, Covance

Dawn Torrence Ireland, President and Founder, C.H.E.R.U.B.S.

Rachel Jao, Vice President, Accounts & Analytics,, Context Matters Inc

Rachel Jao at World Pharma Pricing and Market Access

Navin Joshi, Head of Pricing & Access Capabilities EMAP, GlaxoSmithKline

Navin Joshi at World Pharma Pricing and Market Access

Marcela Junqueira, Head of Value Demonstration and Access, Shire Farmacêutica Brasil Ltda

Marcela Junqueira at World Pharma Pricing and Market Access

Sachin Kamal-Bahl, Vice President & Head, Global Health & Value Innovation Center, Pfizer

Sachin Kamal-Bahl at World Pharma Pricing and Market Access

Abdulkadir Keskinaslan, Head Medical Education Strategy LACan, Novartis Ag

Shameer Khader, Program Director (Healthcare Data Science and Bioinformatics), Northwell Health

Shameer Khader at World Pharma Pricing and Market Access

Diane Kleinermans, Advisor to the Ministry of Health and Social Affairs Belgium, Belgian Federal Government

Margarita Landeira, Associate Director, EMEA Health Economics & Outcomes Research, Astellas Pharma

Margarita Landeira at World Pharma Pricing and Market Access

Bruce Lavin, Vice President and Head of Medical Neurology, UCB

Sebastien Le Roux, VP, Global Market Access & Healthcare Solutions, Glaxo Smith Kline Inc

Sally Lee, Director of Pharmacodepidemiology EMEA / APAC, Celgene

Sally Lee at World Pharma Pricing and Market Access

Giovanny Leon, Pricing and Market Access Director for Latin America and Canada, Novartis Ag

Giovanny Leon at World Pharma Pricing and Market Access

Friedhelm Leverkus, Director Health Technology Assessment and Outcomes Research, Pfizer

Friedhelm Leverkus at World Pharma Pricing and Market Access

Ben locwin, President, Healthcare Science Advisors, Roche & Genentech

Ben locwin at World Pharma Pricing and Market Access

Francois Lucas, Principal Consultant, Pope Woodhead

Alasdair MacCulloch, Regional Market Access Director, Amicus Therapeutics U.K. Ltd

Alasdair MacCulloch at World Pharma Pricing and Market Access

Laura Mace, Engagement Manager, Lifescience Dynamics Ltd

Laura Mace at World Pharma Pricing and Market Access

Mark MacGregor, Associate Medical Director and Clinical Advisor, Scottish Medicines Consortium, NHS National Services Scotland

Mark MacGregor at World Pharma Pricing and Market Access

Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway

Steinar Madsen at World Pharma Pricing and Market Access

Joerg Mahlich, Head HEOR, Janssen Pharmaceutical K.K.

Joerg Mahlich at World Pharma Pricing and Market Access

Farzana Malik, Vice President Market Access, Vicarius Pharma

Farzana Malik at World Pharma Pricing and Market Access

Andrea Mantovani, Director of Country Market Access, Amgen Inc

Andrea Mantovani at World Pharma Pricing and Market Access

Marco Marchetti, Director of the National Center for Health Technology Assessment, Istituto Superiore di Sanita

Anne Marciniak, Affiliate, Brunel University

Anne Marciniak at World Pharma Pricing and Market Access

Robert Meadowcroft, CEO, The Muscular Dystrophy U.K.

Derick Mitchell, Chief Executive Officer, The Irish Platform for Patient Organisations and Science and Industry

Derick Mitchell at World Pharma Pricing and Market Access

Patrick Mollon, Director GHEORE, Shire

Patrick Mollon at World Pharma Pricing and Market Access

Thomas Mueller, Head of Pharmaceuticals, G-BA

Thomas Mueller at World Pharma Pricing and Market Access

Neil Mulcock, Vice President Government Affairs and Policy, Gilead Sciences

Neil Mulcock at World Pharma Pricing and Market Access

Diane Munch, Head of Global Pricing, Patient & Health Impact, Pfizer

Diane Munch at World Pharma Pricing and Market Access

Jeff Myers, CEO, Medicaid Health Plans of America

Jeff Myers at World Pharma Pricing and Market Access

Sue Naeyaert, Global Head Government Affairs and Policy Biosimilars, Fresenius Kabi

Sue Naeyaert at World Pharma Pricing and Market Access

Siva Narayanan, Vice President, PTC

Alexander Natz, Secretary General, EUCOPE

Enkeleida Nikai, Director of RWE - Medical Affairs, Eli Lilly

Enkeleida Nikai at World Pharma Pricing and Market Access

Nneka Onwudiwe PharmD PhD MBA, PRO/PE Regulatory Reviewer, US Government

Robert Orzechowski, Chief Operating Officer, Lancaster Cancer Centre

Robert Orzechowski at World Pharma Pricing and Market Access

Detlev Parow, Head of Department Care and Management Development, D.A.K. Gesundheit Zentrale

Britta Paschen, VP, Head of Global Evidence and Value Development, Merck KGaA

Britta Paschen at World Pharma Pricing and Market Access

Mauro Patroncini, Pipeline Product Strategy Leader, Roche

Mauro Patroncini at World Pharma Pricing and Market Access

Dan Pettitt, Global Head of Immunology Market Access, Johnson & Johnson

Dan Pettitt at World Pharma Pricing and Market Access

Ed Pezalla, Former Vice President, National Medical Director for Pharmaceutical Policy and Strategy, Aetna

Ed Pezalla at World Pharma Pricing and Market Access

Lara Pippo, Head of Market Access, C.S.L. Behring Spa

Lara Pippo at World Pharma Pricing and Market Access

Anna Ponzianelli, Institutional Affairs and Rome Office Head, Novartis

Anna Ponzianelli at World Pharma Pricing and Market Access

Klaas Postema, Senior Director Market Access & Pricing Generics Europe, Teva

Klaas Postema at World Pharma Pricing and Market Access

Tanya Potashnik, Director Policy & Economic Analysis, Patented Medicine Prices Review Board, Goverment Of Canada

Diann Potestio, Senior Director, Market Access, West, Genzyme

Diann Potestio at World Pharma Pricing and Market Access

John Procter, Head of Market Access Europe, IQVIA

John Procter at World Pharma Pricing and Market Access

Malcolm Qualie, Pharmacy Lead for Specialised Services, NHS England

Malcolm Qualie at World Pharma Pricing and Market Access

Marco Rauland, Global Head Pricing & Payer Excellence, Merck Group

Marco Rauland at World Pharma Pricing and Market Access

Andreia Ribeiro, Engagement Manager, Lifescience Dynamics Ltd

Andreia Ribeiro at World Pharma Pricing and Market Access

Gella Richards, Teaching Fellow, Queen Mary University of London

Gella Richards at World Pharma Pricing and Market Access

Anne Toni Rodgers, Former Global Head Operations Payer And Real World Evidence, AstraZeneca

Anne Toni Rodgers at World Pharma Pricing and Market Access

Giuseppe Rosano, Member of the Cardiovascular Working Party, European Medicines Agency

Giuseppe Rosano at World Pharma Pricing and Market Access

Katja Rudell, Patient Services Manager, Shire Pharmaceuticals

Fabian Schmidt, Head of Market Access and External Affairs, Orphan Europe

Fabian Schmidt at World Pharma Pricing and Market Access

Gundula Schneidewind, Vice President, Takeda

Michael Schroter, Head of Personalised Reimbursment Models, Global Pricing and Market Access, Roche

Michael Schroter at World Pharma Pricing and Market Access

Donato Scolozzi, Member of Spending Review Working Group, Ministry of Health Italy

Donato Scolozzi at World Pharma Pricing and Market Access

Rob Scott, Chief Medical Officer, VP, Head of Development, AbbVie

Simon Shohet, Senior Director, Global Market Access and Pricing, Ipsen

Erik Smets, Vice President, Head of Patient Experience and Value, U.C.B. Pharma

Erik Smets at World Pharma Pricing and Market Access

Jayne Spink, Chief Executive Officer, Genetic Alliance U.K.

Jayne Spink at World Pharma Pricing and Market Access

Richard Stephens, Chair of Consumer Liaison Group, National Cancer Research Institute

Bertrand Tardivel, Head of Global Pricing, Takeda Pharmaceuticals International

Bertrand Tardivel at World Pharma Pricing and Market Access

Sam Taylor, Global Pricing Director, Pfizer Ltd

Sam Taylor at World Pharma Pricing and Market Access

Keiko Tone, VP Market Access, Shionogi Limited

Keiko Tone at World Pharma Pricing and Market Access

Dimitar Tonev, Medical Director, Promethera Biosciences

Dimitar Tonev at World Pharma Pricing and Market Access

Dimitrios Tsourougiannis, Associate Director, EMEA Health Economics & Outcomes Research, Astellas Pharma Europe Ltd

Dimitrios Tsourougiannis at World Pharma Pricing and Market Access

Jane Turner, Senior Principal, Real World Evidence, ICON

Jane Turner at World Pharma Pricing and Market Access

Maarten Van Baelen, Market Access Director, Medicines for Europe

Ellen Vanhaeren, Advisor, Minister for Social Security and Public Health, Belgian Federal Government

Ellen Vanhaeren at World Pharma Pricing and Market Access

Peter Vanovertveld, Senior Vice President, Head of Global Pricing & Market Access, Vifor Pharma

Peter Vanovertveld at World Pharma Pricing and Market Access

Bart Vermeulen, Deputy Director Healthcare at Office of the Minister of Social Affairs and Public Health, Belgian Federal Government

Bart Vermeulen at World Pharma Pricing and Market Access

Peter Wahl, Director, Covance

Reg Waldeck, Market Access Strategy Leader, Bayer Corp

Reg Waldeck at World Pharma Pricing and Market Access

David Watson, Director Pricing and Reimbursement, Association of the British Pharmaceutical Industry

Clive Whitcher, Vice President of Global Pricing and Patient Access, Sobi

Clive Whitcher at World Pharma Pricing and Market Access

Entela Xoxi, Research Fellow, Universita Cattolica Del Sacro Cuore

Entela Xoxi at World Pharma Pricing and Market Access

Ruth Zeidman, Director, Covance

Jie Zhang, Executive Director of Global Access Disease Product Lead for Oncology, Novartis Pharmaceuticals

Jie Zhang at World Pharma Pricing and Market Access

Fabrizio Zucca, Director Patient Access DACH, Sobi

Fabrizio Zucca at World Pharma Pricing and Market Access

 

REGISTER NOW